NasdaqGS:IBRXBiotechs
Is ImmunityBio (IBRX) Still Attractive After A 365% Year To Date Surge
If you are wondering whether ImmunityBio's share price still offers value after a strong run, it helps to step back and look carefully at what the market is currently pricing in.
The stock last closed at US$9.40, with returns of 14.5% over the past week, 8.0% over the past month, 365.3% year to date, 229.8% over one year and negative 61.9% over five years. This gives a mixed picture of recent momentum and longer term experience for shareholders.
Recent headlines around ImmunityBio have...